Strong Revenue Growth
Butterfly Network delivered $82.1 million in revenue for 2024, representing a 25% top-line growth. The fourth quarter saw a 35% increase in revenue compared to the prior year period, reaching $22.4 million, the highest quarterly result in the company's history.
iQ3 Commercial Success
The launch of iQ3 was a commercial success, representing 50% of overall 2024 sales in units and 58% of probe revenue. It delivered higher ASPs than the second-generation device.
International Expansion
Butterfly received EU MDR for iQ+ and iQ3, allowing for the European launch and expanded access to new markets in Asia. This is expected to power international growth in 2025.
Successful Capital Raise
Butterfly raised $81.7 million from a follow-on offering in January 2025, providing a bridge to cash flow independence and enabling continued investment in growth initiatives.
Positive Developments in HomeCare
A pilot agreement for lung ultrasound services in Wisconsin showed positive results, with no patient readmissions and improved care for congestive heart failure patients.
Improved Adjusted EBITDA
Adjusted EBITDA loss improved by 42% for the full year 2024, from $67.5 million in 2023 to $38.9 million in 2024, driven by higher revenue and cost reductions.